AU5390579A - Compositions of thiazolidine-4-carboxylic acid - Google Patents

Compositions of thiazolidine-4-carboxylic acid

Info

Publication number
AU5390579A
AU5390579A AU53905/79A AU5390579A AU5390579A AU 5390579 A AU5390579 A AU 5390579A AU 53905/79 A AU53905/79 A AU 53905/79A AU 5390579 A AU5390579 A AU 5390579A AU 5390579 A AU5390579 A AU 5390579A
Authority
AU
Australia
Prior art keywords
thiazolidine
carboxylic acid
salt
agent
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU53905/79A
Other languages
English (en)
Inventor
Not Given Name
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gosalvez Mario G
Original Assignee
Gosalvez Mario G
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gosalvez Mario G filed Critical Gosalvez Mario G
Publication of AU5390579A publication Critical patent/AU5390579A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicinal Preparation (AREA)
AU53905/79A 1978-12-21 1979-12-17 Compositions of thiazolidine-4-carboxylic acid Abandoned AU5390579A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US05/971,729 US4384001A (en) 1978-12-21 1978-12-21 Treatment of tumors with thiazolidine-4-carboxylic acid
US971729 1978-12-21

Publications (1)

Publication Number Publication Date
AU5390579A true AU5390579A (en) 1980-06-26

Family

ID=25518727

Family Applications (1)

Application Number Title Priority Date Filing Date
AU53905/79A Abandoned AU5390579A (en) 1978-12-21 1979-12-17 Compositions of thiazolidine-4-carboxylic acid

Country Status (16)

Country Link
US (1) US4384001A (enExample)
JP (1) JPS55115822A (enExample)
AU (1) AU5390579A (enExample)
BE (1) BE880744A (enExample)
CA (1) CA1149284A (enExample)
DE (1) DE2951050A1 (enExample)
DK (1) DK542979A (enExample)
ES (1) ES8102108A1 (enExample)
FR (1) FR2444459A1 (enExample)
GB (1) GB2039736B (enExample)
IL (1) IL58948A0 (enExample)
IT (1) IT1193348B (enExample)
LU (1) LU82013A1 (enExample)
NL (1) NL7909199A (enExample)
SE (1) SE7910300L (enExample)
ZA (1) ZA796918B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE53332B1 (en) * 1980-03-14 1988-10-26 Efamol Ltd Pharmaceutical compositions
JPS57128625A (en) * 1981-01-30 1982-08-10 Rikagaku Kenkyusho Carcinostatic
US4335210A (en) * 1981-02-11 1982-06-15 Cornell Research Foundation Method of producing L-cysteine
FR2547729B1 (fr) * 1983-06-24 1986-05-02 Riker Laboratories Inc Medicament a base d'acide dl thiazolidine carboxylique
FR2547728B1 (fr) * 1983-06-24 1986-05-02 Riker Laboratories Inc Medicament a base d'acide d thiazolidine carboxylique
DE3586683T2 (de) * 1984-12-18 1993-04-08 Clark Pharma Dev Antitumorzusammensetzungen enthaltend ein reaktionsprodukt zwischen einem cytotoxischen aldehyd und penicillamin und deren verwendung zur herstellung von arzneimitteln.
JPH066578B2 (ja) * 1985-12-27 1994-01-26 三共株式会社 チアゾリジン誘導体
JPH01170063U (enExample) * 1988-05-11 1989-11-30
JPH0467539U (enExample) * 1990-10-18 1992-06-16
ES2092539T3 (es) * 1991-01-10 1996-12-01 Transcend Therapeutics Inc Uso de derivados de la tiazolidina-4-carboxilato para el tratamiento de enfermedades pulmonares.
NZ287139A (en) * 1994-06-14 1997-07-27 Dainippon Pharmaceutical Co Naphthyridine derivatives; preparative process and anti-tumour medicaments
ES2277787B1 (es) * 2006-01-02 2008-06-16 Universidad De Cadiz Empleo de tioprolina en tratamientos de reduccion de peso corporal.

Also Published As

Publication number Publication date
SE7910300L (sv) 1980-06-22
BE880744A (fr) 1980-06-19
CA1149284A (en) 1983-07-05
FR2444459A1 (fr) 1980-07-18
ES487052A0 (es) 1980-12-16
FR2444459B1 (enExample) 1983-04-01
GB2039736B (en) 1983-04-13
JPS55115822A (en) 1980-09-06
DK542979A (da) 1980-06-22
US4384001A (en) 1983-05-17
JPS6328045B2 (enExample) 1988-06-07
GB2039736A (en) 1980-08-20
IT1193348B (it) 1988-06-15
IL58948A0 (en) 1980-03-31
NL7909199A (nl) 1980-06-24
DE2951050A1 (de) 1980-07-10
IT7928170A0 (it) 1979-12-18
LU82013A1 (fr) 1981-02-03
ZA796918B (en) 1980-11-26
ES8102108A1 (es) 1980-12-16

Similar Documents

Publication Publication Date Title
AU528892B2 (en) Polymer-polyol compositions
AU520475B2 (en) Derivatives of dehydrocyclicimino acids
AU531536B2 (en) Dental compositions
AU524193B2 (en) Clavulanic acid composition
AU528642B2 (en) Sunblock formulation
AU530212B2 (en) Production of detergent compositions
AU516719B2 (en) Preparation of cis-hexahydrodibenzopyranones
AU4344579A (en) Nitro-bromo-alkanol compositions
AU4575279A (en) 17 beta-thiocarboxylic acid esters of 4-halo-3-oxoandrost-4- enes
AU529337B2 (en) 5-phenylcarbamoylbarbituric acid compounds
AU533516B2 (en) Manufacture of aza-spirodecanes
AU5147679A (en) Preparation of 2-chlorosulfinylazetidinones
AU528337B2 (en) Derivatives of pyrrolidinecarboxaldehyde
AU530738B2 (en) Fasciolicidal compositions
GB2036749B (en) Preparation of usodeoxycholic acid
AU514609B2 (en) Unitized uric acid test composition
GB2042511B (en) -lactone derivatives of 2-hydroxy-cyclopentane-carboxylic acid
AU5003679A (en) Monocarboxylates of phenylguanidinesulphonic acid
AU6013780A (en) Compositions of benzothiazolones
ZA791403B (en) Composition of matter
AU518548B2 (en) Manufacture of chocolate
AU518218B2 (en) Thiazolylacetic acid compounds
AU520396B2 (en) Preparation of thiazoline-4-one-acetic acid derivatives
JPS5520773A (en) Manufacture of n*nndimethylaminobenzoic acid
AU519331B2 (en) Preparation ofp-hydroxyphenylacetic acid